Clinical significance of the serial measurement of autoantibodies to neutrophil cytoplasm using a standard indirect immunofluorescence test

American Journal of Nephrology

Volumn 15, Issue 3, 1995, Pages 201-207

  Davenport, A ^a   Lock, R J ^b   Wallington, T ^b  

^a Department of Renal Medicine ^*  (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

Antineutrophil cytoplasm autoantibodies; Infection; Recurrence prediction; Wegener s granulomatosis

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; GRANULOCYTE ANTIBODY; METHYLPREDNISOLONE; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY FUNCTION; MALE; PATIENT MONITORING; PLASMA VISCOSITY; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE; RETROSPECTIVE STUDY; WEGENER GRANULOMATOSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOANTIBODIES; COHORT STUDIES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW-UP STUDIES; HUMAN; MALE; MIDDLE AGE; PREDICTIVE VALUE OF TESTS; RECURRENCE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TIME FACTORS; WEGENER'S GRANULOMATOSIS;

EID: 0029068022     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000168833     Document Type: Article

References (21)

1. Faber V, Elling P, Norup G, Mansa NI: An antinuclear factor specific for leukocytes. Lancet 1964;ii:344-345.
2. van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, van der Giessen M, van der Hem GK, The TH: Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener’s granulomatosis. Lancet 1985;i:425-429.
3. Falk RJ, Jennette JC: Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotising and crescentic glomerulonephritis. N Engl J Med 1988;318:1651-1657.
4. Andrassay K, Koderisch J, Rufer M, Erb A, Waldherr R, Ritz E: Detection and clinical implication of antineutrophil cytoplasm antibodies in Wegener’s granulomatosis and rapidly progressive glomerulonephritis. Clin Nephrol 1989;32:159-167.
5. Savage COS, Lockwood CM: Antineutrophil antibodies in vasculitis. Adv Nephrol 1990;19:225-236.
6. Nolle B, Specks U, Ludemann J, Rohrbach MS, Deremee RA, Gross WL: Anticytoplasmic autoantibodies: Their immunodiagnostic value in Wegener’s granulomatosis. Ann Intern Med 1989;111:28-40.
7. Cohen Tervaert JW, van der Woude FJ, Fauci AS, Ambrus JL, Velosa J, Keane WF, Meijer S, van der Giessen M, The TH, van der Hem GK, Kallenberg CGM: Association between active Wegener’s granulomatosis and anticytoplasmic antibodies. Ann Intern Med 1989;149:2461-2465.
8. Specks U, Wheatley CL, McDonald TJ, Rohrbach MS, Deremee RA: Anticytoplasmic autoantibodies in the diagnosis and folow-up of Wegener’s granulomatosis. Mayo Clin Proc 1989;64:28-36.
9. Cohen Tervaert JW, Huitema MG, Hene RJ, Slutter WJ, The TH, van der Hem GK, Kallenberg CGM: Prevention of relapses in Wegener’s granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 1990;336:709-711.
10. Mustonen J, Soppi E, Pasternack A, Hallstrom O: Clinical significance of autoantibodies against neutrophil cytoplasmic components in patients with renal disease. Am J Nephrol 1990;10:482-488.
11. Weidemann S, Andrassay K, Ritz E: ANCA in haemodialysis patients. Nephrol Dial Transplant, in press.
12. Davenport A: False-positive perinuclear and cytoplasmic antibody results leading to a misdiagnosis of Wegener’s granulomatosis and/or microscopic polyarteritis. Clin Nephrol 1992;37:124-130.
13. Barlow JE, Fauci AS: Vasculitic diseases of the kidney: Polyarteritis nodosa, Wegener’s granulomatosis, allergic angiitis and granulomatous and other disorders: in Scroder RW, Gottschalk CW (eds): Diseases of the Kidney, ed 4, New York, Little, Brown, 1988, pp 2335-2360.
14. Hagen EC, Andrassy K, Chernok E, Daha MR, Gaskin G, Gross W, Lesavre P, Ludemann J, Pusey CD, Rasmussen N, Savage CO, Sinico A, Wiik A: The value of indirect immunofluorescence and solid phase techniques for ANCA detection. J Immunol Methods 1993;159:1-16.
15. Lock RJ: Detection of autoantibodies to neutrophil cytoplasmic antigens. J Clin Pathol 1994;47:4-8.
16. Kallenberg CGM, Brouwer E, Weening JJ, Cohen Tervaert JW: Antineutrophil cytoplasmic antibodies: Current diagnostic and pathophysiological potential. Kidney Int 1994;46:1-15.
17. Gaskin G, Savage COS, Ryan JJ, Jones S, Rees AJ, Lockwood CM, Pusey CD: Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis. Nephrol Dial Transplant 1991;6:689-694.
18. Pettersson E, Heigl Z: Antincutrophil cytoplasmic antibody (cANCA and pANCA) titers in relation to disease activity in patients with necrotising vasculitis: A longitudinal study. Clin Nephrol 1992;37:219-228.
19. Hind CRK, Winearls CG, Lockwood CM, Rees AJ, Pepsy B: Objective monitoring of activity in Wegener’s granulomatosis by measurement of serum C reactive protein concentration. Clin Nephrol 1984;21:341-345.
20. Lesavre P: Antineutrophil autoantibodies: Antigen specificity. Am J Kidney Dis 1991;18:159-163.
21. Kerr GR, Fleischer THA, Hallahan CW, Leavitt RY, Fauci AS, Hoffman GS: Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener’s granulomatosis. Arthritis Rheum 1993;36:365-371.